A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis
Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Tuberculosis is currently treated with a 6-month course regimen. During this time many
patients might fail to adhere to treatment and default, increasing the risk of recurrent
disease which might be multidrug resistant. A shorter duration of treatment is expected to
provide improved patient compliance and at least equal or better clinical outcome. The aim of
the trial is to evaluate the efficacy and safety of a gatifloxacin-containing regimen of four
months duration for the treatment of pulmonary tuberculosis,